Apoptosis and multistage carcinogenesis in rat liver

被引:46
作者
SchulteHermann, R [1 ]
Bursch, W [1 ]
GraslKraupp, B [1 ]
Mullauer, L [1 ]
RuttkayNedecky, B [1 ]
机构
[1] INST TUMORBIOL KREBSFORSCH,VIENNA,AUSTRIA
关键词
apoptosis; carcinogenesis; preneoplasm; neoplasm;
D O I
10.1016/0027-5107(95)00134-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Apoptosis is a type of active cell death. It is involved in the homeostasis of cell number in tissues and is controlled by the growth regulatory network in the organism. It is also involved in the active removal of damaged cells. We have studied the role of apoptosis in cancer pre-stages and overt cancer in vivo, using rat liver as our main model system. Quantitative determination of apoptosis in histological specimens revealed that the rate of apoptosis tends to increase from normal to (pre)neoplastic to malignant cells. Thereby active cell death largely counterbalances the increasing replicative activity in developing malignancy. Tumor promoters shift the balance in favor of cell replication, whereas promoter withdrawal, fasting or TGF-beta 1 favor apoptosis (anti-promotion). Preneoplastic cells are more susceptible than normal liver cells to stimulation of both cell replication or cell death. Consequentially (pre)neoplastic tissue may preferentially grow or die during the appropriate treatment. Regimens that favor apoptosis and lower cell replication are shown to result in the elimination of preneoplastic cell clones from the liver (anti-initiation) and to reduce the cancer risk of the animal.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 43 条
[1]  
Bursch, Lauer, Influence of liver tumor promoters on cell death by apoptosis in rat liver, Naunyn-Schmiedeberg's Arch. Pharmacol., (1983)
[2]  
Bursch, Lauer, Timmermann-Trosiener, Barthel, Schuppler, Schulte-Hermann, Controlled cell death (apoptosis) of normal and putative neoplastic cells in rat liver following withdrawal of tumor promoters, Carcinogenesis, 5, pp. 53-58, (1984)
[3]  
Bursch, Paffe, Putz, Barthel, Schulte-Hermann, Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats, Carcinogenesis, 11, pp. 847-853, (1990)
[4]  
Bursch, Liehr, Sirbasku, Putz, Taper, Schulte-Hermann, Control of cell death (apoptosis) by diethylstilbestrol in an estrogen dependent kidney tumor, Carcinogenesis, 12, pp. 855-860, (1991)
[5]  
Bursch, Fesus, Schulte-Hermann, Apoptosis (‘programmed’ cell death) and its relevance in liver injury and carcinogenesis, Tissue Specific Toxicology: Biochemical Mechanisms, (1992)
[6]  
Bursch, Oberhammer, Schulte-Hermann, Cell death by apoptosis and its protective role against disease, Trends Pharmacol. Sci., 13, pp. 245-251, (1992)
[7]  
Bursch, Oberhammer, Jirtle, Askari, Setdivy, Grasl-Kraupp, Purchio, Transforming growth factor-β1 as a signal for induction of cell death by apoptosis, Br. J. Cancer, 67, pp. 531-536, (1993)
[8]  
Bursch, Apoptosis and cancer therapy, New Approaches in Cancer Pharmacology: Drug Design and Development, 2, (1994)
[9]  
Bursch, Kienzl, Ellinger, Schulte-Hermann, Cell death in cultured human mammary carcinoma cells (MCF-7) after treatment with the antiestrogens tamoxifen and ICI 164 384, Hepatology, 21, pp. 1465-1468, (1995)
[10]  
Clarke, Purdie, Harrison, Morris, Bird, Hooper, Wyllie, Thymocyte apoptosis induced by p53-dependent and independent pathways, Nature, 462, pp. 849-852, (1993)